AAC
Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Other Versions of this Article:
AAC.00658-07v1
52/7/2395    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Google Scholar
Right arrow Articles by Calbo, E.
Right arrow Articles by Garau, J.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Calbo, E.
Right arrow Articles by Garau, J.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, July 2008, p. 2395-2402, Vol. 52, No. 7
0066-4804/08/$08.00+0     doi:10.1128/AAC.00658-07
Copyright © 2008, American Society for Microbiology. All Rights Reserved.

Systemic Expression of Cytokine Production in Patients with Severe Pneumococcal Pneumonia: Effects of Treatment with a β-Lactam versus a Fluoroquinolone{triangledown}

Esther Calbo,1* Montserrat Alsina,2 Mónica Rodríguez-Carballeira,1 Josep Lite,3 and Javier Garau1

Service of Internal Medicine, Infectious Diseases Unit, Hospital Mútua de Terrassa, Barcelona, Spain,1 Immunology Department, Hospital Mútua de Terrassa, Barcelona, Spain,2 Service of Microbiology, Hospital Mútua de Terrassa, Barcelona, Spain3

Received 20 May 2007/ Returned for modification 2 August 2007/ Accepted 15 April 2008

Bacterial alveolar invasion is followed by an inflammatory response. A systemic extension of the compartmentalized immune response has been described in patients with severe pneumonia. The data suggest that some antimicrobials may induce a differential release of cytokines. We conducted a prospective, randomized study in adult patients with severe pneumococcal pneumonia to measure the effects of ceftriaxone and levofloxacin in the systemic cytokine expression over time. Demographic, clinical characteristics, and severity scores were recorded. The serum concentrations of tumor necrosis factor alpha (TNF-{alpha}), interleukin-1β (IL-1β), IL-6, IL-8, IL-10, and IL-1 receptor agonist were measured at 0, 24, 72, and 120 h. A total of 32 patients were included in the study. Both groups were homogeneous in terms of age, comorbidities, severity of disease, and corticosteroid or statin use. With the single exception of IL-1β, all cytokines were detected in venous blood. All of the cytokines studied showed a similar pattern of progressive decrease over time. No significant differences in the concentrations of any of the cytokines studied were found, with the exception of TNF-{alpha}, for which lower concentrations were obtained at 120 h in the levofloxacin group (P = 0.014). Basal oxygen saturation (P = 0.034) and heart rate (P = 0.029) returned to normal values earlier in the levofloxacin arm. We demonstrated that in patients with severe pneumococcal pneumonia pro- and anti-inflammatory responses could be detected in venous blood, representing a systemic extension of the compartmentalized response. Treatment with a β-lactam agent or a fluoroquinolone has different effects on cytokine production and its systemic expression, impacting the clinical course of the disease.


* Corresponding author. Mailing address: Infectious Diseases Unit, Service of Internal Medicine, Hospital Mútua de Terrassa, Plaza Dr Robert 5, 08221 Terrassa, Barcelona, Spain. Phone: 34-93-7365050, ext. 3931. Fax: 34-93-7365037. E-mail: esthercalbo{at}hotmail.com

{triangledown} Published ahead of print on 21 April 2008.


Antimicrobial Agents and Chemotherapy, July 2008, p. 2395-2402, Vol. 52, No. 7
0066-4804/08/$08.00+0     doi:10.1128/AAC.00658-07
Copyright © 2008, American Society for Microbiology. All Rights Reserved.







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
Clin. Vaccine Immunol. Clin. Microbiol. Rev.
J. Clin. Microbiol. ALL ASM JOURNALS

Copyright © 2008 by the American Society for Microbiology. All rights reserved.